Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Targacept to discontinue development of TC-6499 for neuropathic pain

March 12, 2009

Medicure cleared to commence phase II Avastrem trial for tardive dyskinesia

March 12, 2009

Schering-Plough presents novel gamma-secretase modulators

March 12, 2009

Novel nAChR receptor modulators claimed by NeuroSearch

March 12, 2009

NK3 receptor antagonists claimed by Roche

March 12, 2009

Solasia initiates clinical development of its first drug in Japan

March 11, 2009

Synosia enters second agreement with Roche for new-generation 5-HT6 antagonist

March 11, 2009

Intra-Cellular Therapies reports final results for phase II ITI-007 trial

March 11, 2009

GlaxoSmithKline identifies a novel EP1 receptor antagonist for the treatment of inflammatory pain

March 11, 2009

EC designates KNS-760704 as orphan medicinal product for ALS

March 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...